BWEN vs REGN · P/E 15, rev $42.2M vs P/E 14, rev $4.29B
Broadwind Energy Inc (BWEN) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Broadwind Energy Inc (BWEN) is a specialty industrial machinery company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported BWEN revenue for 2026-06-30 was $42.2M. Net income was -$1.1M. Revenue was up 24.1% from 2026-03-31 to 2026-06-30. BWEN currently screens at market cap $82.1M and trailing P/E 15.3.
Latest reported REGN revenue for 2026-06-30 was $4.29B. Net income was $1.30B. Revenue was up 19.0% from 2026-03-31 to 2026-06-30. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
BWEN currently screens at market cap $82.1M and trailing P/E 15.3. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the BWEN and REGN stock pages for the full models.
Not investment advice.